Viewing Study NCT06275334


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-27 @ 9:23 AM
Study NCT ID: NCT06275334
Status: RECRUITING
Last Update Posted: 2024-02-23
First Post: 2024-02-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dinutuximab Beta at the HUS and the Toulouse Oncopole
Sponsor: University Hospital, Strasbourg, France
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Outcomes Module Eligibility Module Contacts Locations Module